COVID-19: OSIBANJO PLEDGES ACCESSIBILITY TO VACCINE

241

In accordance with President Buhari’s vision of securing the health and safety of Nigerian citizens, the Federal Government in collaboration with Pfizer has pledged easy accessibility to the COVID-19 Vaccine in the country when developed.

Prof. Yemi Osinbajo, Nigeria’s Vice President disclosed this during a virtual meeting with the representatives of BNT162 COVID-19 Vaccine Candidate on the progress of the vaccine development around the world, including Africa.

The BNT162 is a vaccine candidate promoted by two International pharmaceutical giants; Pfizer and BioNtech.

Prof. Osinbajo who stressed the importance of the collaboration with the promoters of the vaccine candidate said that, “it is an important conversation and it is important for us that we are prioritized as the largest country in Africa in the distribution of the best COVID-19 vaccine when it’s eventually ready”.

He further reiterated that the Federal Government is examining every possible option in getting the COVID-19 Vaccine readily available to Nigerians when developed.

Mr. Subair Olayinka, Pfizer Country Manager and Representative in Africa, commended the effort of the Nigerian government in combatting the virus. He further disclosed that as soon as the COVID-19 Vaccine is developed, “Nigeria will be priority,” for the vaccine supply to Africa.

MrOlayinka further confirmed that the vaccine trials are ongoing in some parts of the African continent and it would be entering the third phase, having concluded the first two phases successfully.

In his contribution, Dr. Osagie Ehanire, Honourable Minister of Health noted that the Federal Government would consider quality, appropriate volume, how well and quick a vaccine can be delivered to Nigeria in deciding which manufacturer will make the supply.

Africa’s most populous country has recorded over 47,000 confirmed Coronavirus cases and 950 deaths, but low levels of testing have left a beclouded picture of the outbreak severity in the country.

LEAVE A REPLY

Please enter your comment!
Please enter your name here